SQIDF SQI Diagnostics Inc.

SQI Diagnostics, Inc. is a life sciences and diagnostics company. It develops multiplexed tests and automated systems for customers who need to measure a variety of biomarkers in blood or other common sample types and commercialize proprietary technologies and products for microarray diagnostics. The firm offers solutions to pharmaceutical and biotechnology drug development, human diagnostic testing and animal health diagnostic tests. The company was founded by Peter Lea in 1999 and is headquartered in Toronto, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.14    OTCQB
As of 01/25/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  Canada
Country of incorporation:  
IPO date:  08/11/2009
Outstanding shares:  389,463,134
Average volume:  55,520
Market cap:   $56,277,423
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   -5.22
PB ratio:   14.45
PS ratio:   54.90
Return on equity:   -285.65%
Net income %:   -1,050.93%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy